MedCognetics, Inc., a company focusing on medical imaging AI, today announced that Innovative Health & Wellness has selected the company's AI technology to support breast imaging across its network of outpatient imaging centers. The implementation reflects a growing commitment among leading imaging providers to combine physician expertise with advanced AI to strengthen diagnostic confidence, improve workflow efficiency, and help identify breast cancers as early as possible.
Breast cancer remains one of the most common cancers affecting women, and early detection continues to be one of the most important factors in improving outcomes. At the same time, radiologists face growing imaging volumes and increasing demands for timely, accurate interpretation. AI has emerged as an important clinical decision-support technology, helping physicians identify subtle findings while maintaining the radiologist at the center of every diagnosis.
"At Innovative Health & Wellness, we believe women deserve the very best that modern medicine has to offer, combining compassionate care, experienced radiologists, and the most advanced imaging technology available," said Robert Shields, Chief Executive Officer, Innovative Health & Wellness. "Artificial intelligence is becoming an important extension of the radiologist, providing additional insights that support earlier detection and greater diagnostic confidence without replacing clinical judgment. By incorporating MedCognetics' AI into our breast imaging program, we're investing in technology that helps our physicians deliver even better care for every patient we serve."
Innovative Health & Wellness provides comprehensive diagnostic imaging services, with a focus on advanced technology, patient comfort, clear communication, and expert radiologist oversight. By incorporating MedCognetics' AI into its breast imaging program, the organization is expanding its ability to deliver timely, high-quality care while supporting physicians with additional clinical insights throughout the screening process.
“We owe patients the best care possible,” said Debasish "Ron" Nag, Chief Executive Officer, MedCognetics. “Experienced physicians, state-of-the-art imaging, and responsible AI are essential to supporting timely, accurate diagnoses and better outcomes. MedCognetics’ technology is designed to fit seamlessly into the radiology workflow, giving physicians additional insights that can improve confidence, support earlier detection, and ultimately help deliver better outcomes for patients.”
MedCognetics develops FDA-cleared AI software that integrates seamlessly into existing radiology workflows, providing physicians with decision-support tools that complement clinical expertise while helping improve efficiency and consistency in breast cancer screening.
The value of this technology has already been demonstrated in real-world screening environments. In India, MedCognetics’ AI supported a mobile breast cancer screening program with Health Within Reach Foundation that screened more than 6,500 women, approximately 90% of whom had never had a mammogram before. The program identified 600-plus abnormal findings and helped connect more than 44 cancer-positive patients to treatment before the disease could progress further. The lesson is practical: AI can strengthen breast imaging workflows, support timely follow-up, and keep more women engaged in preventive care.
"Our vision at Innovative Health & Wellness is to redefine breast care by combining compassionate, patient-centered service with the latest advancements in medical technology," said Shital Patel, Breast Center Administrator, Innovative Health & Wellness. "Our collaboration with MedCognetics reflects our commitment to equipping our radiologists with innovative AI tools that enhance early detection, improve diagnostic confidence, and ultimately provide women with the highest standard of breast care."
As healthcare organizations continue to adopt AI-assisted imaging technologies, MedCognetics remains focused on developing solutions that enhance physician performance, integrate seamlessly into clinical workflows, and improve the quality and accessibility of breast cancer screening for patients around the world.